See more : Real Estate Credit Investments Limited (RECI.L) Income Statement Analysis – Financial Results
Complete financial analysis of Japan Hospice Holdings Inc. (7061.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Japan Hospice Holdings Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- NTN Corporation (6472.T) Income Statement Analysis – Financial Results
- Salmones Camanchaca S.A. (SLMCF) Income Statement Analysis – Financial Results
- DDC Enterprise Limited (DDC) Income Statement Analysis – Financial Results
- Biostage, Inc. (BSTG) Income Statement Analysis – Financial Results
- Hongkong Land Holdings Limited (HKLB.L) Income Statement Analysis – Financial Results
Japan Hospice Holdings Inc. (7061.T)
About Japan Hospice Holdings Inc.
Japan Hospice Holdings Inc. engages in hospice housing and home care businesses in Japan. The company offers care services at hospice housing for patients with terminal cancer and intractable diseases; and home-visit nursing services. It also provides home care services, which supports medical care, including physical care and life support, as well as offers day and nursing multi-function home care services. The company was founded in 2017 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 9.87B | 7.89B | 6.02B | 4.92B | 4.19B | 3.02B | 1.90B |
| Cost of Revenue | 7.95B | 6.31B | 4.90B | 4.06B | 3.20B | 2.37B | 1.54B |
| Gross Profit | 1.92B | 1.58B | 1.12B | 860.20M | 989.77M | 641.64M | 351.61M |
| Gross Profit Ratio | 19.48% | 20.03% | 18.59% | 17.49% | 23.60% | 21.28% | 18.55% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 72.00M | 68.00M | 48.00M | 65.00M | 90.00M | 72.00M | 76.23M |
| Selling & Marketing | 272.00M | 315.12M | 294.95M | 266.72M | 250.76M | 212.95M | 0.00 |
| SG&A | 344.00M | 383.12M | 342.95M | 331.72M | 340.76M | 284.95M | 76.23M |
| Other Expenses | 295.00M | 106.46M | 25.20M | 4.51M | -3.72M | 1.78M | 1.66M |
| Operating Expenses | 639.82M | 621.64M | 520.86M | 501.69M | 488.59M | 398.84M | 301.88M |
| Cost & Expenses | 8.59B | 6.93B | 5.42B | 4.56B | 3.69B | 2.77B | 1.85B |
| Interest Income | 17.00K | 13.00K | 9.00K | 8.00K | 4.00K | 3.00K | 2.00K |
| Interest Expense | 350.59M | 282.89M | 205.90M | 156.96M | 110.74M | 111.00M | 92.21M |
| Depreciation & Amortization | 411.74M | 336.76M | 228.61M | 169.51M | 129.38M | 125.80M | 112.10M |
| EBITDA | 1.79B | 1.40B | 852.01M | 532.54M | 627.55M | 435.38M | 163.49M |
| EBITDA Ratio | 18.14% | 17.77% | 14.15% | 10.83% | 14.95% | 12.28% | 8.63% |
| Operating Income | 1.28B | 959.32M | 598.18M | 358.51M | 501.18M | 242.79M | 49.73M |
| Operating Income Ratio | 13.00% | 12.15% | 9.94% | 7.29% | 11.95% | 8.05% | 2.62% |
| Total Other Income/Expenses | -255.36M | -174.99M | -180.69M | -152.45M | -113.75M | -44.21M | -90.55M |
| Income Before Tax | 1.03B | 784.33M | 417.49M | 206.07M | 387.43M | 198.59M | -40.82M |
| Income Before Tax Ratio | 10.42% | 9.94% | 6.94% | 4.19% | 9.24% | 6.59% | -2.15% |
| Income Tax Expense | 346.45M | 305.58M | 176.69M | 99.01M | 89.53M | 49.13M | 19.67M |
| Net Income | 681.88M | 454.73M | 240.80M | 107.06M | 297.89M | 149.46M | -60.49M |
| Net Income Ratio | 6.91% | 5.76% | 4.00% | 2.18% | 7.10% | 4.96% | -3.19% |
| EPS | 84.82 | 56.73 | 30.29 | 13.62 | 40.30 | 20.08 | -8.53 |
| EPS Diluted | 84.26 | 56.27 | 29.85 | 13.31 | 38.50 | 20.08 | -8.13 |
| Weighted Avg Shares Out | 8.04M | 8.02M | 7.95M | 7.86M | 7.39M | 7.44M | 7.09M |
| Weighted Avg Shares Out (Dil) | 8.09M | 8.08M | 8.07M | 8.05M | 7.74M | 7.44M | 7.44M |
Source: https://incomestatements.info
Category: Stock Reports